Table.
Demographic and Baseline Characteristics
| Parameter | Patients (n = 28) |
|---|---|
| Female, n (%) | 28 (100) |
| Age, y, mean ± SD (range) | 40.5 ± 8.8 (23-56) |
| Race, n (%) | |
| White | 25 (89.3) |
| Black | 2 (7.1) |
| Asian | 1 (3.6) |
| Hispanic/Latino, n (%) | 7 (25.0) |
| Fitzpatrick skin type, n (%) | |
| II | 9 (32.1) |
| III | 11 (39.3) |
| IV | 5 (17.9) |
| V | 3 (10.7) |
| BMI, kg/m2, mean ± SD (range) | 25.9 ± 4.6 (19.6-41.0) |
| BMI category, n (%) | |
| Normal (18.5 to <25 kg/m2) | 12 (42.9) |
| Overweight (25 to <30 kg/m2) | 12 (42.9) |
| Obese (≥30 kg/m2) | 4 (14.3) |
| Location of cellulite treated, n (%) | |
| Buttock only | 22 (78.6) |
| Thigh only | 3 (10.7) |
| Buttock and thigh | 3 (10.7) |
| Prior nonsurgical cosmetic procedures, n (%) | 17 (60.7) |
| Injectables: fillers | 13 (46.4) |
| Injectables: botulinum toxin type A | 7 (25.0) |
| Injectables: deoxycholic acid (Kybella; Allergan, Madison, NJ) | 2 (7.1) |
| Laser (Sciton, Palo Alto, CA) | 2 (7.1) |
| Cellulaze (Cynosure, Westford, MA) | 1 (3.6) |
| CoolSculpting (Allergan Aesthetics, Pleasanton, CA) | 1 (3.6) |
| Injectables: poly-L-lactic acid (Sculptra; Galderma Laboratories, Fort Worth, TX) | 1 (3.6) |
| Microneedling | 1 (3.6) |
| Ultrasound cellulite treatment | 1 (3.6) |
| VelaShape (Candela Medical, Marlborough, MA) | 1 (3.6) |
| Prior surgical cosmetic procedures, n (%) | 16 (57.1) |
| Liposuction | 9 (32.1) |
| Breast augmentation/breast implant | 7 (25.0) |
| J-plasma device (Apyx Medical, Clearwater, FL) | 6 (21.4) |
| Rhinoplasty/septoplasty/nose reconstruction | 5 (17.9) |
| Abdominoplasty | 4 (14.3) |
| BBL/fat transfer to buttock | 2 (7.1) |
| Mastopexy | 2 (7.1) |
| Otoplasty (bilateral, external ear) | 1 (3.6) |
| Recti diastasis repair | 1 (3.6) |
| Skin removal | 1 (3.6) |
BBL, Brazilian butt lift; BMI, body mass index; SD, standard deviation.